Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.

As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Director, US Compliance will serve as a strategic compliance business partner across all business functions, reporting to the VP, US Compliance. This role is responsible for providing proactive compliance advice and counsel as the company prepares for future product commercialization.

This role requires a firm understanding of pharmaceutical industry codes and regulations, healthcare laws, and compliance risk assessment and management, as well as a strong ability to advise on interactions with the healthcare community and other external stakeholders. The individual will play an integral part in ensuring company activities are conducted in accordance with applicable healthcare laws, regulations, industry codes, and internal policies while enabling business objectives in a compliant and ethical manner. The Director will collaborate cross-functionally with Commercial, Medical Affairs, Clinical Development, Patient Advocacy, Legal, Regulatory, Finance, and other stakeholders to support the compliant execution of Revolution Medicines’ business activities.

This role requires the ability to balance operational execution with strategic leadership in a dynamic and evolving organization.

Key Responsibilities

will include: Product Launch and Healthcare Community Engagement Support Provide timely, practical, and risk-based compliance advice and counsel on healthcare compliance and policy

Requirements

related to Revolution Medicines interactions with the healthcare community, including disease education programs, promotional and nonpromotional activities, consulting engagements, advisory boards, external funding, patient assistance programs, patient advocacy group interactions, payer interactions, and other similar activities. Support the review and approval of promotional and nonpromotional materials and patient engagement programs to ensure regulatory compliance. Advise on compliance with False Claims Act, Anti-Kickback Statute (AKS), Foreign Corrupt Practices Act (FCPA), and state/federal transparency laws.

Collaboration with Healthcare Law Partner closely with the Healthcare Law team to ensure consistency between legal interpretation and compliance operations.

Responsibilities

between Compliance and Healthcare Law. Collaborate to deliver integrated, practical, and risk-appropriate guidance to internal clients – particularly within Commercial, Medical Affairs, Clinical Development, and Market Access functions. Compliance Risk Assessments, Investigations, and Mitigation Identify and escalate compliance risks, and support development of mitigation strategies.

Conduct compliance risk assessments related to commercial and medical activities, external stakeholder engagements, and other business activities. Lead investigations into potential compliance violations, ensuring timely, thorough resolution and corrective actions. Support implementation of corrective and preventive actions resulting from monitoring or audit activities.

Training, Communications, and Compliance Program Support Support operational execution of healthcare compliance policies and processes.